Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Rapid Novor Inc.
*MAILING ADDRESS
137 Glasgow St., Unit 450
*CITY
Kitchener, Ontario
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
Canada
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
N2G4X8
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION
Canada
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
*IDENTIFICATION
Proteomics analysis test kits comprising reagents for detecting, quantifying and characterizing antibody proteins in a biological sample for
scientific research purposes; Medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting cancer, autoimmune diseases and infections; Development of new technology
for others in the field of biotechnology; Proteomics analysis services; Antibody profiling for scientific research purposes; Laboratory research in the field of immune sequencing; Medical and
scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of immune sequencing; Providing medical and scientific research information in the
field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals; Research and analysis in the field of medicine; Research and development in the
pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Medical laboratory services; Providing medical
diagnostic and prognostic testing for cancer, autoimmune diseases and infections, and the analysis, evaluation, and reporting of test results to help healthcare professionals determine a patient's
clinical diagnosis, the effectiveness of treatments, and to revise future treatments accordingly; providing medical diagnostic and prognostic testing services; consulting services in the field of
medical diagnostic testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the
submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
CORRESPONDENCE INFORMATION
NAME
Rapid Novor Inc.
DOCKET/REFERENCE NUMBER
0253429.0002
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE
agalloway@millerthomson.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES)
daschnurr@millerthomson.com
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Standard
NUMBER OF CLASSES
1
APPLICATION FOR REGISTRATION PER CLASS
275
*TOTAL FEES DUE
275
*TOTAL FEES PAID
275
SIGNATURE INFORMATION
SIGNATURE
/DAVIDSCHNURR/
SIGNATORY'S NAME
David Schnurr
SIGNATORY'S POSITION
Authorized Canadian Attorney
SIGNATORY'S PHONE NUMBER
+1-
DATE SIGNED
08/13/2020
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Serial Number:90112581
Filing Date:08/13/2020
To the Commissioner for Trademarks:
MARK: NOVORIG (Standard Characters, see mark)
The literal element of the mark consists of NOVORIG. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Rapid Novor Inc., a corporation of Canada, having an address of
137 Glasgow St., Unit 450
Kitchener, Ontario N2G4X8
Canada
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class _______: Proteomics analysis test kits comprising reagents for detecting, quantifying and characterizing antibody proteins in a biological sample for scientific research
purposes; Medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting cancer, autoimmune diseases and infections; Development of new technology for others in the
field of biotechnology; Proteomics analysis services; Antibody profiling for scientific research purposes; Laboratory research in the field of immune sequencing; Medical and scientific research in
the field of cancer treatment and diagnosis; Medical and scientific research in the field of immune sequencing; Providing medical and scientific research information in the field of clinical trials;
Providing medical and scientific research information in the fields of pharmaceuticals; Research and analysis in the field of medicine; Research and development in the pharmaceutical and
biotechnology fields; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Medical laboratory services; Providing medical diagnostic and
prognostic testing for cancer, autoimmune diseases and infections, and the analysis, evaluation, and reporting of test results to help healthcare professionals determine a patient's clinical
diagnosis, the effectiveness of treatments, and to revise future treatments accordingly; providing medical diagnostic and prognostic testing services; consulting services in the field of medical
diagnostic testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on Canada application number 2045788, filed 08/13/2020.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the
foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
The applicant's current Correspondence Information:
Rapid Novor Inc.
PRIMARY EMAIL FOR CORRESPONDENCE: agalloway@millerthomson.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): daschnurr@millerthomson.com
The docket/reference number is 0253429.0002.
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /DAVIDSCHNURR/ Date: 08/13/2020
Signatory's Name: David Schnurr
Signatory's Position: Authorized Canadian Attorney
Payment Sale Number: 90112581
Payment Accounting Date: 08/13/2020
Serial Number: 90112581
Internet Transmission Date: Thu Aug 13 16:42:45 ET 2020
TEAS Stamp: USPTO/BAS-XX.X.XXX.XX-202008131642453086
36-90112581-740a014aa213cb4ff7a3b5d99b7d
b5eae1f5942d958e88dd6e6395caf73da7e7-CC-
42438883-20200813163843274050